KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Accumulated Expenses (2018 - 2026)

Emergent BioSolutions has reported Other Accumulated Expenses over the past 9 years, most recently at $8.0 million for Q1 2026.

  • For Q1 2026, Other Accumulated Expenses fell 27.93% year-over-year to $8.0 million; the TTM value through Mar 2026 reached $8.0 million, down 27.93%, while the annual FY2025 figure was $10.8 million, 50.68% down from the prior year.
  • Other Accumulated Expenses for Q1 2026 was $8.0 million at Emergent BioSolutions, down from $10.8 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $67.6 million in Q3 2024 and troughed at $8.0 million in Q1 2026.
  • A 5-year average of $25.3 million and a median of $24.1 million in 2025 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 79.84% in 2022 and later skyrocketed 76.96% in 2024.
  • Year by year, Other Accumulated Expenses stood at $45.9 million in 2022, then decreased by 28.76% to $32.7 million in 2023, then tumbled by 33.03% to $21.9 million in 2024, then plummeted by 50.68% to $10.8 million in 2025, then decreased by 25.93% to $8.0 million in 2026.
  • Business Quant data shows Other Accumulated Expenses for EBS at $8.0 million in Q1 2026, $10.8 million in Q4 2025, and $24.1 million in Q3 2025.